Seventure Partners, subsidiary of Natixis (BPCE group) realized the final close of Health for Life Capital at €160m, above its initial target of €120m.
The Fund invests in health and nutrition, especially in microbiota and connected health sectors.
Health for Life Capital received strong support from industrials such as Danone, Novartis, Tereos, Lesaffre, Bel, Tornier, from institutional investors (fund of funds, pension funds, insurance and banks) and also from family offices.
The Fund has already realized several investments in Europe and USA: Enterome, LNC, Maat pharma, Micropharma, Eligo bioscience, Targedys, Humedics, etc.
Jasmin Capital was the placement agent for Health for Life Capital.
- Pitchbook – Seventure Partners Health for Life Capital fund totals €160M
- CF News – Seventure boucle son fonds santé
- Capital Finance – Soutenu par Novartis, Health for Life Capital clôt à 160 M€
- AFP – Seventure Partners accueille un acteur majeur de l’industrie pharmaceutique en tant qu’investisseur stratégique dans Health for Life Capital